| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.90B | +3.5% |
| Cost of Revenue | $48.34B | +9.4% |
| R&D Expense | $851.0M | -0.7% |
| SG&A Expense | $1.68B | +1.8% |
| Interest Expense | $662.0M | -9.4% |
| Pre-tax Income | $6.09B | -25.2% |
| Income Tax | $1.45B | -16.7% |
| Net Income | $4.64B | -27.6% |
| EPS (Basic) | $6.32 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.89B | +30.1% |
| Accounts Receivable | $5.61B | -18.0% |
| Inventory | $6.99B | -5.2% |
| Current Assets | $20.48B | -1.8% |
| Total Assets | $60.60B | -3.8% |
| Current Liabilities | $11.33B | -14.3% |
| Long-term Debt | $15.06B | +3.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.47B | +6.6% |
| Investing Cash Flow | -$2.97B | -1.9% |
| Financing Cash Flow | -$3.36B | +44.6% |
| -25.1% |
| EPS (Diluted) | $6.28 | -25.1% |
| Stockholders' Equity |
| $20.72B |
| +14.1% |